Richard Callaghan
- Oncology top 0.5%
- Molecular Biology top 2%
- Pediatrics, Perinatology and Child Health top 0.5%
- Infectious Diseases top 2%
- Organic Chemistry top 5%
- Co-authors
- Christopher F. HigginsHoward R. MellorRobert C. FordCatherine MartinMatthew D. HallIan D. KerrSzabolcs ModokMark F. Rosenberg
- Topics
- Drug Transport and Resistance Mechanisms (71 papers)Pharmacological Effects and Toxicity Studies (16 papers)Maritime and Coastal Archaeology (14 papers)
- Journals
- NatureProceedings of the National Academy of SciencesJournal of the American Chemical Society
- Partner nations
- United KingdomAustraliaCanada
In The Last Decade
Richard Callaghan
130 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Oncology 4.3k
- Molecular Biology 2.8k
- Pediatrics, Perinatology and Child Health 1.1k
- Infectious Diseases 799
- Organic Chemistry 522
Countries citing papers authored by Richard Callaghan
This map shows the geographic impact of Richard Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Callaghan more than expected).
Fields of papers citing papers by Richard Callaghan
This network shows the impact of papers produced by Richard Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Callaghan. The network helps show where Richard Callaghan may publish in the future.
Co-authorship network of co-authors of Richard Callaghan
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Callaghan. A scholar is included among the top collaborators of Richard Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Callaghan. Richard Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 46 | |
| 2 | 9 | |
| 3 | 7 | |
| 4 | 11 | |
| 5 | 3 | |
| 6 | 10 | |
| 7 | Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells | 1 |
| 8 | 20 | |
| 9 | 17 | |
| 10 | 28 | |
| 11 | 21 | |
| 12 | 28 | |
| 13 | 96 | |
| 14 | 51 | |
| 15 | 165 | |
| 16 | 13 | |
| 17 | 97 | |
| 18 | 1 | |
| 19 | 12 | |
| 20 | 75 |
About Richard Callaghan
Richard Callaghan is a scholar working on Oncology, Geography, Planning and Development and Paleontology, having authored 130 papers that have together received 6.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (71 papers), Pharmacological Effects and Toxicity Studies (16 papers) and Maritime and Coastal Archaeology (14 papers). The work is most often cited by research in Oncology (4.3k citations), Geography, Planning and Development (314 citations) and Molecular Medicine (284 citations). Richard Callaghan has collaborated with scholars based in United Kingdom, Australia and Canada. Frequent co-authors include Christopher F. Higgins, Howard R. Mellor, Robert C. Ford, Catherine Martin, Matthew D. Hall, Ian D. Kerr, Szabolcs Modok, Mark F. Rosenberg, G. Berridge and Trevor W. Hambley. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.